Intensity Therapeutics, Inc. Announces First Patient Dosed in Its Global Randomized, Phase 3 Study (Invincible-3) in Metastatic Soft Tissue Sarcoma
Intensity Therapeutics, Inc. 公佈全球範圍內隨機的第三期(無敵3)轉移性軟組織肉瘤研究已完成首例患者的投藥
Intensity Therapeutics, Inc. Announces First Patient Dosed in Its Global Randomized, Phase 3 Study (Invincible-3) in Metastatic Soft Tissue Sarcoma
Intensity Therapeutics, Inc. 公佈全球範圍內隨機的第三期(無敵3)轉移性軟組織肉瘤研究已完成首例患者的投藥
譯文內容由第三人軟體翻譯。